Interprofessional Outpatient Clinic Polypharmacy Management. Objectives

Similar documents
Learning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications

Case Studies in T2DM A Comprehensive Management Approach

Pharmacy Partnership to Improve Patient Outcomes

Polypharmacy & De-prescribing In Older Adults

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?

OBESITY IN TYPE 2 DIABETES

Appendix A: Sample Patient Profiles and Prescriptions

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Matching, Fill in the Blank, Multiple Choice (1 point each)

Complete this CE activity online at ProCE.com/InsulinPart2

Polypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference

Wayne Gravois, MD August 6, 2017

Collaborative Practice Agreement

Role of the Clinical Pharmacist in Primary Care

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Background. 1 11/20/2011 Steven Chen, PharmD; Sun Han, PharmD, USC School of Pharmacy

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Renee Flores, MD Division of Geriatrics & Palliative Medicine Department of Internal Medicine

Intervention to improve adherence to Type 2 Diabetes mellitus subjects in rural teaching hospital

Objectives. The Good, The Bad and The Iatrogenic. The FDA Package Insert renal dosing is dependent on. Nephrology Axiom 4/10/15

Meds and Falls: Keep in Step with your Meds

Geriatric vs. Non-Geriatric Anticoagulation Management

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

Case #3 Clinician. Past Medical History: hypertension, hypercholesterolemia, arthritis, seasonal allergies, remote history of stroke

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Individualizing Care for Patients with Type 2 Diabetes

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD

ROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP

Cases of Patients with OUD. Objectives

Cardiology Cath Conference

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine

Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients?

Objectives. Kidney Complications With Diabetes. Case 10/21/2015

A Process for Performing Medication Assessments

Insulin Optimisation Workshop. Theingi Aung & Claire Rowell

Management of Novel Oral Anticoagulants (NOACs) with the DAWN AC modules

Patient Getting Smart About Medications Education If the kidneys are not working well, less waste is removed, including

A Practical Approach to the Use of Diabetes Medications

It takes a Village: Medication Management Partnering with patients to optimize medication outcomes

Intensification of Diabetic Therapy. Case studies

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor

Alaska Medicaid 90 Day** Generic Prescription Medication List

AGS Annual Meeting May Sponsored by the Polypharmacy Special Interest Group and the Pharmacists Section

CURRENT ISSUES IN DIABETES MANAGEMENT. Screening for Diabetes Advantages of HbA1c as a Diagnostic Test. Diagnosis of Diabetes 2013

Diagnosis Coding. Tips, Guidelines & Common Errors. Amy Jack, Risk Adjustment Coding Auditor, RHIT, CCA, CRC

Innovative Pharmacy Services: Boldly Going Where No Pharmacist Has Gone Before. Learning Objectives

11/4/2014. Outline. Pharmacists Objectives. Diabetes Update: What s New in Pharmacy Technician Objectives. Overview: Type 2 Diabetes Mellitus

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Clinical Pearls in Renal Medicine

:{ic0fp'16. Geriatric Medicine: Optimal Heart Health Amid Changing Guidelines. (and the Evidence for When to Stray) Kevin Overbeck, DO

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Preventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Titration Algorithm

Have participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call, , mail).

Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015

Individualizing Treatment Plans for Older Adults With T2DM

Finding the sweet spot: Individualized targets for older adults with Type 2 DM

Challenging Patients: Elderly Patient With Multiple Co morbidities Essentials of Family Medicine 1

5/16/2018 COGNITIVE HEALTH AND DIABETES WORKSHOP I HAVE NO FINANCIAL CONFLICTS OF INTEREST

PATTERNS OF MEDICATION USE IN THE UNITED STATES

The Latest Generation of Clinical

Evaluating the Cardiovascular Benefits of Antidiabetic Medications

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Adverse drug interactions in dental practice

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

5/8/2017. Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

Evaluation and Treatment of Hypertension

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Difficult to Treat Hypertension

Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Save on your drugs with HealthyRx

Effectively Implementing Medical-Behavioral Integration

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Demystifying the Complex Patient

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Advanced Strategies and Measurement. Foresight Family Physicians Primary Care Partners The Telluride Medical Center

Clinical Cases in Diabetes Management. Joseph Cook D.O.

8/12/2016. Diabetes Management Across the Spectrum of Kidney Function. Andrew Bzowyckyj. Learning Objectives. Ashley Crowl

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45

Professionalism & Service with Great Prices

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

Managing Complex Diabetic Patients in the Primary Care Setting. Tyree Morrison, CRNP, CDE Laura Previte, RN, BSN

Chronic Opioid Therapy Safe Prescribing in Primary Care. Part 3

Practice Brilliantly with Previsit Planning

Management: How Can We Do Better? Lori B. Sweeney, MD 2018 Virginia ACP Clinical Update March 17, 2018

IT S MORE OF AN ART : MANAGING INSULIN THERAPY IN THE OLDER PATIENT

Hypertension Pharmacotherapy: A Practical Approach

Presenter Contact Information: Thomas McCloskey PharmD, MS

APhA March 2016 Annual Meeting Obesity Cases

Box, UAE Tel: Fax:

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

Transcription:

Interprofessional Outpatient Clinic Polypharmacy Management Brett Hoffecker, MD University of Kansas School of Medicine Wichita Family Medicine Residency Program at Via Christi April 10th, 2015 Objectives Demonstrate the role of the pharmacist in outpatient chronic disease management and polypharmacy use Discuss the interprofessional Clinician / Pharmacist relationship Identify effects on patient outcomes 2 1

63 yo AA Male Poorly controlled DM2 CKD Stage 3 HTN HLD Anemia of chronic disease Peripheral neuropathy Lower extremity edema Alcohol abuse Chronic pain on narcotics Tobacco use Depression Poor adherence 3 Chlorthalidone 12.5 mg Daily Losartan 50 mg Daily Rosuvastatin 40 mg Daily Gabapentin 100 mg TID Linagliptin, 5.0 mg Daily Insulin Glargine 13.0 units qhs Insulin Aspart 3.0 units TIDAC Albuterol 90 mcg/inh q4hr PRN Omeprazole 40 mg Daily Sucralfate QIDACHS Loperamide 2 mg q4hr PRN Hydrocodone/acetaminophen 10 mg 325 mg q6hr PRN Vitamin B12 1000.0 mcg Daily Vitamin C 500 mg Daily Cetirizine 10 mg Daily 4 2

Extreme fluctuations in symptoms, poor understanding of how/when/which medications to take, hypoglycemic episodes Started meeting with our clinic pharmacist who initially spent an hour reviewing meds and counseling Found to have expired meds, overdosing, not taking as prescribed, multiple drug side effects and interactions 5 Next Several Months Consolidated med list Adherence Improved Symptoms Improved A1C decreased 9.5% to 6.1% 6 3

73 yo AA Male Uncontrolled type 2 DM HTN CAD and MI w/ stents Obesity Asthma 7 Atorvastatin 40 mg Daily Lisinopril hydrochlorothiazide 20 mg 25 mg Daily Metformin 1000 mg BID Metoprolol tartrate 100 mg BID Amlodipine 10 mg Daily Clopidogrel 75 mg Daily Glyburide micronized 6mg BID 8 4

Uncontrolled symptoms and A1C 10.8% Started meeting with our clinic pharmacist weekly after the 2 nd visit Found to have lack of understanding of chronic disease, diet and exercise with poor adherence 9 Next Couple Months Concerns with insulin use as a truck driver Changed to Liraglutide (Victoza) Patient education: chronic disease, meds, diet and exercise Address barriers to care (cost of meds/ needles) Improved symptoms and medication adherence 10 5

55 yo Hispanic Male Uncontrolled type 2 DM Peripheral neuropathy Diabetic foot ulcer HTN Morbid obesity Chronic back pain 11 Aspirin 81 mg Daily Atorvastatin 40 mg Daily Enalapril 5 mg Daily Hydrochlorothiazide 12.5 mg Daily Insulin glargine 50 units daily Metformin 1000 mg BID 12 6

A1C 13.6% to 6.9% then up to 8.3% BMI increased from 44 to 48 Began involving our clinic pharmacist on a regular basis Identified lack of understanding, demotivation, uncontrolled symptoms 13 Next Couple Months Education: obesity, nutrition, chronic disease, DM Made insulin changes Close follow up with phone and office visits Accountability and coaching Improved symptoms and medication adherence 14 7

Pharmacist skill sets Comprehensive medication reviews Education/accountability/coaching Decreasing/overcoming cost and logistical barriers Parameters of medication management Optimizing initial physician orders in collaboration Discussing recommendations/modifications with physicians Documenting interval patient adherence 15 Transition from residency to community setting Can do in many settings, not only rural and residencies 16 8

Communication Location Pharmacist Involvement Access to EMR Reimbursement Pharmacy student involvement Quality improvement projects Collaborative practice agreements (CDTM collaborative drug therapy management) 17 Collaboration Kansas passed new law in 2014 for physician/pharmacist allowing collaboration practice agreements Physician can refer patients to pharmacist (Can get INR checked at pharmacy and have coumadin adjusted). Reimbursement methods not well established Regulations are still being developed 18 9

Outcomes Optimizing patient care Increasing clinician efficacy and efficiency Close follow up and evaluation of adherence Helping physicians reach objectified markers Collaboration between clinicians and pharmacists 19 "If you don't have enough time, then you need a bigger team." ~ Loral Langemeier 20 10